Positron emission tomography (PET) scans of the heart can help to identify people, known to be at risk for…
Articles by Margarida Maia, PhD
Mission Therapeutics’ experimental oral therapy MTX325, for Parkinson’s disease, spurred brain cells in mice to clear damaged mitochondria…
Toxic clumping of the alpha-synuclein protein, a hallmark of Parkinson’s disease, may lead to a calcium imbalance in which…
For people with Parkinson’s disease associated with mutations in the GBA gene, deep brain stimulation (DBS) may offer lasting…
Being diagnosed with depression or having symptoms of the condition significantly increases the risk for developing Parkinson’s disease, according…
Regularly practicing the Chinese martial art tai chi may slow the progression of motor and nonmotor symptoms of Parkinson’s…
Parkinson’s UK is funding two new basic research projects at the University of Edinburgh, in Scotland, that have as…
It may be possible to spot telltale signs of Parkinson’s disease on positron emission tomography (PET) scans as early…
Cure Parkinson’s is funding preclinical research that intends to provide the evidence needed to determine whether three existing compounds…
A once-daily 200 mg dose of Inhibikase Therapeutics’ risvodetinib — an oral medication previously called IkT-148009, now undergoing…